KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Operating Margin (2017 - 2025)

Sarepta Therapeutics (SRPT) has 11 years of Operating Margin data on record, last reported at 15.61% in Q4 2024.

  • For Q4 2024, Operating Margin fell 2092.0% year-over-year to 15.61%; the TTM value through Dec 2024 reached 26.22%, up 5359.0%, while the annual FY2024 figure was 191.27%, 21281.0% up from the prior year.
  • Operating Margin reached 15.61% in Q4 2024 per SRPT's latest filing, down from 2.03% in the prior quarter.
  • Across five years, Operating Margin topped out at 8.44% in Q1 2024 and bottomed at 583.93% in Q3 2022.
  • Average Operating Margin over 5 years is 96.1%, with a median of 77.9% recorded in 2023.
  • Peak YoY movement for Operating Margin: crashed -56918bps in 2022, then surged 49128bps in 2023.
  • A 5-year view of Operating Margin shows it stood at 280.3% in 2020, then surged by 66bps to 94.5% in 2021, then soared by 33bps to 63.15% in 2022, then surged by 108bps to 5.31% in 2023, then crashed by -394bps to 15.61% in 2024.
  • Per Business Quant database, its latest 3 readings for Operating Margin were 15.61% in Q4 2024, 2.03% in Q3 2024, and 0.19% in Q2 2024.